Theodore Friedmann
#133,896
Most Influential Person Now
Theodore Friedmann's AcademicInfluence.com Rankings
Theodore Friedmannphilosophy Degrees
Philosophy
#6662
World Rank
#9730
Historical Rank
Logic
#3793
World Rank
#5003
Historical Rank

Theodore Friedmannbiology Degrees
Biology
#9021
World Rank
#12176
Historical Rank
Virology
#205
World Rank
#211
Historical Rank
Biochemistry
#1345
World Rank
#1466
Historical Rank

Download Badge
Philosophy Biology
Theodore Friedmann's Degrees
- Masters Medicine University of Pennsylvania
- PhD Biochemistry University of Pennsylvania
Why Is Theodore Friedmann Influential?
(Suggest an Edit or Addition)Theodore Friedmann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. (1993) (1418)
- Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. (1988) (818)
- The nucleotide sequence of bacteriophage φX174 (1978) (539)
- A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. (1994) (522)
- Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. (1988) (498)
- Base sequence studies of 300 nucleotide renatured repeated human DNA clones. (1981) (485)
- Generation of high-titer pseudotyped retroviral vectors with very broad host range. (1994) (480)
- Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence (1986) (371)
- Progress toward human gene therapy. (1989) (341)
- Analysis of the p53 gene and its expression in human glioblastoma cells. (1994) (340)
- Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1 (1992) (296)
- Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus (1991) (292)
- Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. (1994) (290)
- Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences (1980) (266)
- Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. (1984) (262)
- Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. (1989) (251)
- Isolation and Characterization of a Full-Length Expressible cDNA for Human Hypoxanthine Phosphoribosyltransferase (1983) (237)
- A brief history of gene therapy (1992) (210)
- Grafting genetically modified cells to the brain: Possibilities for the future (1987) (208)
- A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. (1983) (174)
- Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. (1983) (168)
- Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells (1981) (156)
- Expression of a retrovirus encoding human HPRT in mice. (1984) (153)
- Overcoming the obstacles to gene therapy. (1997) (146)
- Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function (1994) (137)
- THE DEVELOPMENT OF HUMAN GENE THERAPY (1999) (132)
- Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. (1989) (129)
- Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease (1994) (122)
- Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. (1997) (121)
- Gene expression from transcriptionally disabled retroviral vectors. (1987) (119)
- Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. (1988) (117)
- Grafting genetically modified cells into the rat brain: characteristics of E. coli beta-galactosidase as a reporter gene. (1989) (109)
- Human gene therapy — an immature genie, but certainly out of the bottle (1996) (107)
- Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. (2011) (106)
- Adenovirus vector infection of chronic lymphocytic leukemia B cells. (1996) (101)
- Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. (1982) (97)
- The nucleotide sequence and genome organization of the polyoma early region: Extensive nucleotide and amino acid homology with SV40 (1979) (95)
- The organization of the human HPRT gene. (1986) (95)
- Concepts and strategies for human gene therapy. (1992) (88)
- Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector. (1984) (85)
- Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase III. (1981) (83)
- Grafting genetically modified cells to the brain: conceptual and technical issues. (1990) (81)
- Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. (1996) (80)
- Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. (1985) (79)
- Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes. (1987) (77)
- The nucleotide sequence of bacteriophage phiX174. (1978) (76)
- Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. (2002) (76)
- Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. (1992) (75)
- Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. (1992) (74)
- Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system (1996) (72)
- Pseudotyped retroviral vectors for studies of human gene therapy (1995) (69)
- Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype (1991) (67)
- Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. (1992) (63)
- Metabolic Cooperation between Genetically Marked Human Fibroblasts in Tissue Culture (1968) (62)
- Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle (1992) (61)
- Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. (1995) (60)
- Gene therapy for neurological disorders. (1994) (60)
- The nucleotide sequence and restriction enzyme sites of the polyoma genome. (1980) (59)
- Influence of Age and Strain on Striatal Dopamine Loss in a Genetic Mouse Model of Lesch‐Nyhan Disease (1999) (58)
- Principles for Human Gene Therapy Studies (2000) (57)
- Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA (1984) (56)
- Amino acid sequence homology between polyoma and SV40 tumour antigens deduced from nucleotide sequences (1978) (55)
- High-efficiency gene transfer into cells. (1987) (54)
- Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. (1983) (54)
- Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. (1992) (54)
- Brain Purines in a Genetic Mouse Model of Lesch‐Nyhan Disease (1993) (53)
- Effect of Host Modification and Age on Airway Epithelial Gene Transfer Mediated by a Murine Leukemia Virus-Derived Vector (1998) (51)
- Gene therapy of cancer through restoration of tumor‐suppressor functions? (1992) (51)
- Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro. (1988) (50)
- Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. (2012) (50)
- Pantropic retroviral vector-mediated gene transfer, integration, and expression in cultured newt limb cells. (1994) (50)
- Enhanced Gene Transfer with Fusogenic Liposomes Containing Vesicular Stomatitis Virus G Glycoprotein (1998) (49)
- Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector. (1996) (49)
- Animal models of Lesch-Nyhan syndrome (1990) (48)
- ASGCT and JSGT Joint Position Statement on Human Genomic Editing. (2015) (46)
- Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. (2002) (45)
- Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome. (1991) (45)
- Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol. (1970) (44)
- Separable Mechanisms of Attachment and Cell Uptake during Retrovirus Infection (2000) (43)
- Structural Roles of Polyoma Virus Proteins (1972) (43)
- Efficient gene expression in mammalian cells from a dicistronic transcriptional unit in an improved retroviral vector. (1991) (43)
- Dose-related analgesic effects of flupirtine. (1991) (42)
- Gene doping in sports: the science and ethics of genetically modified athletes. (2011) (41)
- Variable stability of a selectable provirus after retroviral vector gene transfer into human cells (1986) (40)
- Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis. (2010) (40)
- Evidence against the existence of guanosine and inosine kinases in human fibroblasts in tissue culture. (1969) (40)
- Nucleotide sequence and genetic organization of the polyoma late region: Features common to the polyoma early region and SV40 (1979) (39)
- The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation (2013) (39)
- Nucleotide sequence studies of polyoma DNA. The Hpa II 3/5 junction to the Hpa II 4/Hae III 18 junction, encoding the origin of DNA replication and the 5' end of the early region. (1978) (39)
- Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase (2012) (39)
- Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. (1997) (38)
- HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? (2011) (38)
- The structure of acetylcholinesterase: relationship to its function and cellular disposition (1987) (36)
- In Vitro Cell-Free Conversion of Noninfectious Moloney Retrovirus Particles to an Infectious Form by the Addition of the Vesicular Stomatitis Virus Surrogate Envelope G Protein (1998) (35)
- MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease? (2012) (34)
- Gene Doping and Sport (2010) (34)
- Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors. (1995) (32)
- Autocrine differentiation of PC12 cells mediated by retroviral vectors. (1990) (31)
- A Scientific Perspective (2006) (31)
- Post-transcriptional regulation of retroviral vector-transduced low density lipoprotein receptor activity. (1990) (31)
- Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein. (1993) (31)
- VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection. (2001) (31)
- In vitro reassembly of shell-like particles from disrupted polyoma virus. (1971) (30)
- Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype. (2004) (30)
- Gene therapy in the CNS: intracerebral grafting of genetically modified cells. (1990) (30)
- Polybrene increases the efficiency of gene transfer by lipofection (1998) (30)
- Relative quantitative assay of the biological activity of interferon messenger ribonucleic acid. (1975) (28)
- Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175 (1991) (28)
- Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein. (2005) (28)
- Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization (1992) (26)
- Mechanisms of Action of the p53 Tumor Suppressor and Prospects for Cancer Gene Therapy by Reconstitution of p53 Function (1994) (26)
- Nucleotide sequences at the termini of phi 29 DNA. (1981) (25)
- The human genome project--some implications of extensive "reverse genetic" medicine. (1990) (25)
- Swimming behavior of X and Y human sperm. (1984) (25)
- Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice. (2000) (25)
- Gene transfer : delivery and expression of DNA and RNA : a laboratory manual (2007) (24)
- Transduction of a Drug-Sensitive Toxic Gene into Human Leukemia Cell Lines with a Novel Retroviral Vector (1993) (23)
- Stanfield Rogers: insights into virus vectors and failure of an early gene therapy model. (2001) (23)
- Effects of Choline and Quiescence on Drosophila Choline Acetyltransferase Expression and Acetylcholine Production by Transduced Rat Fibroblasts (1992) (23)
- Genetic economy of polyoma virus: capsid proteins are cleavage products of same viral gene. (1974) (22)
- Retrovirus vector-mediated gene transfer into hepatocytes. (1989) (21)
- Gene transfer and athletics- an impending problem. (2001) (21)
- Gene therapy and the brain. (1995) (21)
- Tissue-specific aberrations of gene expression in HPRT-deficient mice: functional complexity in a monogenic disease? (2007) (20)
- Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection. (1996) (20)
- Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles. (1994) (20)
- Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts (2008) (19)
- Structural proteins of polyoma virus: proteolytic degradation of virion proteins by exogenous and by virion-associated proteases (1976) (18)
- How Close Are We to Gene Doping? (2010) (18)
- Association of Murine Leukemia Virus Pol with Virions, Independent of Gag-Pol Expression (1999) (17)
- Primary structure of acetylcholinesterase: implications for regulation and function. (1986) (17)
- Alzheimer’s disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch–Nyhan disease) (2015) (16)
- Nucleotide sequence changes in polyoma ts-a mutants: correlation with protein structure (1981) (16)
- The road toward human gene therapy--a 25-year perspective. (1997) (16)
- Genetic therapies, human genetic enhancement, and … eugenics? (2019) (15)
- Gene therapy's new era: a balance of unequivocal benefit and unequivocal harm. (2003) (14)
- Replication-defective recombinant herpes simplex virus vectors. (1994) (14)
- Regions of the polyoma genome coding for T antigens. (1979) (14)
- Gene therapy--a new kind of medicine. (1993) (13)
- The evolving concept of gene therapy. (1990) (13)
- The maturation of human gene therapy (1996) (13)
- Next Generation "Omics" Approaches in the "Fight" against Blood Doping. (2017) (13)
- Transduction of foreign regulatory sequences by a replication-defective herpes simplex virus type 1: the rat neuron-specific enolase promoter. (1995) (12)
- Gene therapy: Fact and fiction in biology's new approaches to disease (1983) (12)
- MAST‐CELL DISEASE IN CHILDREN. Report of Eleven Cases. (1967) (11)
- Gene Therapy, Human (2001) (11)
- The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH. (2001) (11)
- Nucleotide sequence of the F protein coding region of bacteriophage phiX174 and the amino acid sequence of its product. (1978) (10)
- Lessons for the Stem Cell Discourse from the Gene Therapy Experience (2005) (10)
- An ASGCT Perspective on the National Academies Genome Editing Summit. (2016) (10)
- Retroviral gene transfer inXenopus cell lines and embryos (1996) (10)
- Medical ethics. Principles for human gene therapy studies. (2000) (10)
- [2] High-efficiency gene transfer into cells (1987) (9)
- Long-term transgene expression from genetically modified hepatocytes grafted to the rat liver. (1992) (9)
- A fractionation method to identify qauntitative changes in protein expression mediated by IGF-1 on the proteome of murine C2C12 myoblasts (2009) (9)
- Epitope insertion into the human hypoxanthine phosphoribosyltransferase protein and detection of the mutant protein by an anti-peptide antibody. (1987) (8)
- Gene therapy for disorders of the nervous system. (1993) (8)
- Implantation of genetically engineered cells to the brain. (1988) (8)
- Differentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor. (1995) (8)
- Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes. (1992) (8)
- In support of mitochondrial replacement therapy (2019) (8)
- Characterization of the gene delivery properties of baculoviral-based virosomal vectors. (2008) (8)
- Knock-in and knock-out. Transgenes, Development and Disease: A Keystone Symposium sponsored by Genentech and Immunex, Tamarron, CO, USA, January 12-18, 1991. (1991) (7)
- A mutation increasing the size of the polyoma virion proteins, VP2 and VP3. (1981) (7)
- Adult mammalian hepatocyte as target cell for retroviral gene transfer: A model for gene therapy (1987) (7)
- Virion proteins of polyoma temperature-sensitive mutants: late mutants. (1975) (7)
- Recombination between a herpes simplex virus type 1 vector deleted for immediate early gene 3 and the infected cell genome. (1992) (7)
- Genetically modified tumor-infiltrating lymphocytes for cancer therapy. (1991) (7)
- Discrepant effects of culture conditions on survival and function of dopaminergic neurons (2004) (6)
- Gene transfer into rat airway epithelial cells using retroviral vectors (1991) (6)
- Changing roles for academia and industry in genetics and gene therapy. (2000) (6)
- Provirus-anchored long-range (PAL) mapping of mammalian genomes. (1993) (5)
- Preparation of pseudotyped lentiviral vectors resistant to inactivation by serum complement. (2010) (5)
- Clinical gene therapy: lessons from the ether dome. (2004) (5)
- A new serious adverse event in a gene therapy study. (2007) (5)
- Approaches to gene therapy in disorders of purine metabolism. (1988) (4)
- Milestone and events in the early development of human gene therapy. (1993) (4)
- Insertion of hypoxanthine phosphoribosyltransferase cDNA into human bone marrow cells by a retrovirus. (1986) (4)
- Bone Marrow Transplantation Does Not Ameliorate the Neurologic Symptoms in Mice Deficient in Hypoxanthine Guanine Phosphoribosyl Transferase (HPRT) (1999) (4)
- HPRT Gene Transfer as a Model for Gene Therapy (1985) (4)
- Lesch-Nyhan disease as a model for central nervous system directed gene therapy (1995) (4)
- Simplified plasmid rescue of host sequences adjacent to integrated proviruses. (1996) (3)
- Partial characterization of the proteome of the mouse striatum (2007) (3)
- 1 The Origins, Evolution, and Directions of Human Gene Therapy (1999) (3)
- Gene transfer vectors for clinical application (2012) (3)
- Correction: HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? (2011) (3)
- origins and prospects (1993) (3)
- Organization of T antigens in the polyoma virus genome. (1980) (3)
- Applications and implications of genome related biotechnology. (1988) (2)
- The Scientific Basis for Gene Therapy: A New Concept in Medicine (2006) (2)
- 834 STABILITY OF GENE TRANSFER IN LESCH NYHAN CELLS (1985) (2)
- Clinical Application of Gene Transfer Technology: Overcoming the Obstacles (2005) (2)
- Gene therapy for disorders of the CNS. (1994) (2)
- Chromosomal sublocalization of human gene sequences by in situ hybridization (1988) (2)
- Nucleotide sequence at polyoma VP1 mRNA splice sites (1981) (2)
- Viral vectors do the DNA shuffle (2000) (2)
- Gene Transfer In Sports: An Opening Scenario For Genetic Enhancement of Normal “Human Traits” (2006) (2)
- A decade of accomplishments: gene therapy and the ASGT. (2007) (1)
- In Vivo Gene Transfer with Retrovirus Vectors (1999) (1)
- Gene expression from a transcriptionally disabled retroviral vector. (1986) (1)
- The ASGT and ethical codes for clinical research. (2008) (1)
- INSERTION OF HYPOXAKTHINE PHOSPHORIBOSYLTRANSFERASE (HPRT) cDNA INTO HUMAN BONE MARROW CELLS (BMC) A RETROVIRUS VECTOR: 75 (1985) (1)
- Early Gene Transfer Experiments: Problems and Eventual Success (2006) (1)
- Immunofluorescent localization of TAMM-HORSFALL mucoprotein (1966) (1)
- HPRT-deficient mice: A useful new animal model for human disease (1987) (1)
- ANALYSIS OF CLONED HUMAN UBIQUITOUS REPEATED DNA SEQUENCES (1980) (1)
- Prospects for human gene therapy in mental retardation and developmental disabilities (1995) (1)
- Genetic technology in doping and doping detection (2011) (0)
- Gene Therapy: I. Strategies for Gene Therapy (1995) (0)
- Abstracts of papers presented at the 1998 Meeting on Gene Therapy, September 23-September 27, 1998 (1998) (0)
- Some Ethical Aspects of “Harm” in Sport (2006) (0)
- Principles of gene transfer and foreign protein expression for human gene therapy (2001) (0)
- 531. Complexes of DNA-Cationic Liposomes with Baculovirus GP64 Envelope Fusion Protein Vesicles Demonstrate Enhanced Transfection Efficiency (2006) (0)
- Preface/Front Matter (1999) (0)
- The Evolution of Human Gene Therapy: A Journey from Excessive Hype to Excessive Diffidence to Reality (2007) (0)
- 186. Secreted Extracellular Vesicles of Baculovirus GP64 Interact with Plasmid DNA to Enhance Transfection (2005) (0)
- Genetics. (Book Reviews: Genetic Interaction and Gene Transfer. Papers from a symposium, Upton, N. Y., May 1977) (1978) (0)
- 335. Global Transcriptional Profiles of Murine C2C12 Myoblasts Treated with IGF-1 (2006) (0)
- 455. Targeting of a Non-Human Coronavirus to Human Tumor Cells by Using a Bispecific Single-Chain Antibody (2003) (0)
- INFORMATION TRANSFER BY CELLULAR MESSENGER RNA (1974) (0)
- Modulator genes in Lesch Nyhan disease Microarray studies (2001) (0)
- The development and evolution of human gene therapy (2010) (0)
- Farewell to professor Shigetaka Asano. (2020) (0)
- 223. Proteomic Analysis of the Striatum of Wild Type and HPRT-Deficient Mouse (2006) (0)
- An approach to the genetic correction of defects and disorders of the central nervous system (1992) (0)
- International Cooperation and Regulation: The Banbury Workshop (2002) (2006) (0)
- 69 THE HPRT PROMOTER (1988) (0)
- Science and society: Scientific and policy progress toward gene therapy (1985) (0)
- New Retroviral Models for Gene Therapy: Swords into Plowshares (1989) (0)
- Characterization of the basal and brain-specific expression of the human hypoxanthine guanine phosphoribosyltransferase gene (1996) (0)
- Nucleotide Sequence atPolyoma VP1mRNA Splice Sites (2013) (0)
- Ethics and Oversight in Clinical Trials: Attempts at Gene Doping Would Not Conform to Accepted Ethical Standards (2006) (0)
- Temporal expression divergence of network modules (2017) (0)
- An integrated funding mechanism for clinical trials in human gene therapy. (2009) (0)
- Simplex Virus Type1Vectors IsDependent onItsPosition, the Infected Cell Type,andthePresence ofVmwl75 (1991) (0)
- Dose-related effects of flupirtine on the pain-related evoked potential (1990) (0)
- A Molecular Genetic Approach to Neuropsychiatric Disease — Some Technical and Ethical Considerations (1991) (0)
- 1 – Milestones and Events in the Early Development of Human Gene Therapy (1993) (0)
- ORGANIZATION OF THE HUMAN HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE GENE: 101 (1985) (0)
- Evidence for integration of retroviral vectors in a novel human repeat sequence (1994) (0)
- A Potential Approach to Gene Therapy of Cancer (1992) (0)
- Happy Anniversary. (2007) (0)
- 400. Transduction of Human Embryonic Stem Cells with Lentiviral Vectors: Variable Promoter Activity in Pluripotent Cells (2004) (0)
- 222. Aberrant Striatal Gene Expression in the Striatum of HPRT-Knockout Mouse (2006) (0)
- Molecular biology and human disease: edited by Alexander Macleod and Karol Sikora, Blackwell Scientific Publications, 1984. £10.80 (xi + 271 pages) ISBN 0 632 01167 X (1985) (0)
- APPENDIX I: The Nucleotide Sequence of the DNA of ϕ X174 cs 70 and the Amino Acid Sequence of the Proteins for Which It Codes (1978) (0)
- CNS therapy using genetically modified cells. (1992) (0)
- Approaches to Gene Therapy in the CNS: Intracerebral Grafting of Fibroblasts Genetically Modified to Secrete Nerve Growth Factor (1989) (0)
- Abstracts of papers presented at the 1994 meeting on gene therapy, September 21-25, 1994 (1994) (0)
- The Birth of a New Form of Medicine—Gene Therapy (2005) (0)
- Inducible expression system for the generation of packaging cell lines for viral vectors pseudotyped retro (1997) (0)
- The construction of the human cDNA library from RNA purified from cell line GM 637 ( Human Genetic Mutant Cell (0)
- Some Issues Affecting Progress Toward Human Gene Therapy and Potential Application to the Lung (2020) (0)
- Abstracts of papers presented at the 1996 Meeting on Gene Therapy, September 25-September 29, 1996 (1996) (0)
- 14 Targets for Gene Therapy (1999) (0)
- Gene Therapy for Neurological Disease (2015) (0)
- RNA Virus Vectors (2000) (0)
- The successful clinical use of viral vectors for human gene therapy. Preface. (2012) (0)
- AN ALTERED HPRT PROTEIN, CREATED BY AN IN VITRO MUTAGENESIS OF THE GENE, CAN BE RECOGNIZED SPECIF: CALLY BY AN ANTIPEPTIDE ANTIBODY: 235 (1985) (0)
- Education, concentration and more efficient transfer of retroviral vectors pseudotyped vsv-g (1994) (0)
- Scientific and policy progress toward gene therapy. (1985) (0)
- Editorial Board Editorial Assistants 255 Reeeptor-mediated Gene Delivery Employing Lectin-binding Speeificity (2011) (0)
- 1.P.117 Gene transfer into the carotid artery using an adventitial collar comparison of the effectiveness of different gene delivery vehicles (1997) (0)
- D. J. JOLLY*, H. OKAYAMAt, P. BERGt, A. C. EsTY*, D. (2016) (0)
- Mechanisms of Retroviral Particle Maturation and Attachment (2003) (0)
- Nucleic Acids Research Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase HI (2005) (0)
- Pseudotype Formation ofMurine Leukemia Viruswith theG Protein ofVesicular Stomatitis Virus (1991) (0)
- Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase (Leseh-Nyhan disease/gene cIoning/h-ansfection/DffA sequenoe analysis) (1983) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Theodore Friedmann?
Theodore Friedmann is affiliated with the following schools: